U of Rochester Spinout CellTraffix Seeks to Bolster IP Position Through MIT Research

Researchers from the Massachusetts Institute of Technology and the University of Rochester have demonstrated how technology developed by UR spinout CellTraffix for selectively “trapping” blood cells might be adapted for human applications such as treating metastases, “reprogramming” stem cells, and diagnosing various diseases.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register quickly here for free access.